Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.09

-0.8

-0.5

-0.21

Details

Expected EPS

-0.212475

Actual EPS

-0.35

Surprise EPS

-0.14

Surprise Percent

+64.73%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.35 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.